Details for New Drug Application (NDA): 215487
✉ Email this page to a colleague
The generic ingredient in REZENOPY is naloxone hydrochloride. There are twelve drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
Summary for 215487
Tradename: | REZENOPY |
Applicant: | Summit Biosci |
Ingredient: | naloxone hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215487
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 10MG/SPRAY | ||||
Approval Date: | Apr 19, 2024 | TE: | RLD: | Yes |
Complete Access Available with Subscription